How new guidelines are ushering in a new era for breast cancer clinical trials 06 Dec 2021 Breast cancer clinical trials have evolved over the years, and with new ideas came new challenges in reporting their results. Molly Andrews explores the ICR’s role in setting out new guidance for recording results from breast cancer clinical trials. Find out more Show/Hide
“I was so young when my mum died” – Danny’s secondary breast cancer story 02 Dec 2021 Danny lost his mum to secondary breast cancer when he was just seven years old. He tells us how he found a community who are helping to fight the disease. Find out more Show/Hide
The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide
Weighing in on breast cancer risk – considering the effect of weight gain before the menopause 13 Mar 2020